Adecatumumab: Difference between revisions
m (Protected "Adecatumumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 35: | Line 35: | ||
{{humanmonoclonals}} | {{humanmonoclonals}} | ||
[[Category:Monoclonal antibodies]] | [[Category:Monoclonal antibodies]] | ||
[[Category:Cancer treatments]] | [[Category:Cancer treatments]] |
Latest revision as of 20:42, 8 August 2012
WikiDoc Resources for Adecatumumab |
Articles |
---|
Most recent articles on Adecatumumab Most cited articles on Adecatumumab |
Media |
Powerpoint slides on Adecatumumab |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Adecatumumab at Clinical Trials.gov Clinical Trials on Adecatumumab at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Adecatumumab
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Adecatumumab Discussion groups on Adecatumumab Patient Handouts on Adecatumumab Directions to Hospitals Treating Adecatumumab Risk calculators and risk factors for Adecatumumab
|
Healthcare Provider Resources |
Causes & Risk Factors for Adecatumumab |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Adecatumumab is a human monoclonal antibody which it's used to target tumor cells. It binds to the epithelial cell adhesion molecule (EpCAM).
External links